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In the present work we examined localization and
behavior of G protein-coupled receptors (GPCR) in po-
larized exocrine cells to address the questions of how
luminal to basal Ca2 waves can be generated in a re-
ceptor-specific manner and whether quantal Ca2 re-
lease reflects partial release from a continuous pool or
an all-or-none release from a compartmentalized pool.
Immunolocalization revealed that expression of GPCRs
in polarized cells is not uniform, with high levels of
GPCR expression at or near the tight junctions. Meas-
urement of phospholipase C activity and receptor-de-
pendent recruitment and trapping of the box domain of
RGS4 in GPCRs complexes indicated autonomous func-
tioning of Gq-coupled receptors in acinar cells. These
findings explain the generation of receptor-specific
Ca2 waves and why the waves are always initiated at
the apical pole. The initiation site of Ca2 wave at the
apical pole and the pattern of wave propagation were
independent of inositol 1,4,5-trisphosphate concentra-
tion. Furthermore, a second Ca2 wave with the same
initiation site and pattern was launched by inhibition of
sarco/endoplasmic reticulum Ca2-ATPase pumps of
cells continuously stimulated with sub-maximal agonist
concentration. By contrast, rapid sequential application
of sub-maximal and maximal agonist concentrations to
the same cell triggered Ca2 waves with different initi-
ation sites. These findings indicate that signaling spec-
ificity in pancreatic acinar cells is aided by polarized
expression and autonomous functioning of GPCRs and
that quantal Ca2 release is not due to a partial Ca2
release from a continuous pool, but rather, it is due to an
all-or-none Ca2 release from a compartmentalized Ca2
pool.
Ca2 signaling by G protein-coupled receptors (GPCR)1 in-
volves the generation of inositol 1,4,5-trisphosphate (IP3) in the
cytosol and Ca2 release from the endoplasmic reticulum (1). In
polarized exocrine cells, Ca2 release is not uniform but occurs
in the form of Ca2 waves. Rooney et al. (2) reported a unique
initiation site and propagation pattern of GPCR-evoked Ca2
waves in hepatocytes. Kasai et al. (3) first described the unique
feature of initiation of Ca2 waves at the apical pole and their
propagation to the basal pole of pancreatic acini. This phenom-
enon was later confirmed in pancreatic acinar cells (3–6) and
was extended to other exocrine cells (7, 8). Subsequent studies
showed that expression of high levels of all IP3 receptor (IP3Rs)
isoforms at the apical pole accounts for the initiation of Ca2
waves at this site (7, 9). Furthermore, the apical pole showed
higher sensitivity to Ca2 release by IP3 than other regions of
the cell, including the basal pole (3, 10, 11). However, since the
discovery of the polarized Ca2 waves in exocrine cells, it
remained a mystery how IP3 can be generated in the apical pole
to initiate the waves. Early functional (12) and radioligand (13)
localization of receptors in tissue slices indicated that GPCRs
are expressed in the basal membrane. Therefore, it was as-
sumed that during GPCR stimulation IP3 generated in the
basal pole diffuses to the apical pole to initiate Ca2 release
and waves (14). This assumption has several difficulties. For
example, at maximal stimulus intensity Ca2 release starts
within few milliseconds of cell stimulation. The diameter of
exocrine acinar cells is about 20 m. This requires exception-
ally high rate of diffusion of IP3 in the cytosol of this cells. In
pancreatic acini, Ca2 release events can remain confined to
the apical pole (3, 4). This requires continuous traffic of IP3
through the cytosol without causing Ca2 release. Another
alternative is generation of IP3 in or close proximity to the
apical pole. This requires localization of GPCR at the apical
pole. With the development of suitable antibodies for immuno-
localization of GPCR and the use of isolated cell clusters that
increase the resolution of immunolocalization, it became possi-
ble to re-examine GPCR localization in relation to initiation of
Ca2 waves.
Another aspect of Ca2 release in terms of initiation and
propagation of Ca2 waves is the architecture of the Ca2 pool
and the dynamics of Ca2 release. Propagation of Ca2 waves
requires either sequential Ca2 release from a compartmental-
ized pool or release from different sections of a continuous pool
along the path of the Ca2 wave. A unique property of Ca2
release from internal stores, the quantal feature of Ca2 re-
lease (15), can reflect the spatial organization of the Ca2 pool
that is needed for propagation of Ca2 waves. Ca2 release
evoked by either stimulation of GPCR (15), activation of the IP3
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receptors (15–17), or activation of the ryanodine receptors (18)
has quantal properties, that is at submaximal stimulus inten-
sity only part of the Ca2 pool is released and at increased
stimulus an increased fraction of the pool is released. Two main
models were proposed to explain quantal release. The first is an
all-or-none release of Ca2 from a compartmentalized pool that
has a continuum of sensitivity to IP3 (15, 19, 20). The second
model proposes phasic Ca2 release from a homogeneous pool
where the phase of release at a given IP3 concentration is
determined by gating of IP3Rs activity by Ca
2 content remain-
ing in the stores (21). The first model fits well with the exper-
imentally observed variable sensitivity of different cellular re-
gions of pancreatic acini to IP3-mediated Ca
2 release (3, 11).
On the other hand, recent work (22) in Xenopus oocytes reports
that the quantal behavior of Ca2 release stems from rapid
adaptation of the IP3R channels of a continuous Ca
2 pool and
claimed to refute the compartmentalization model.
The constancy of initiation of Ca2 waves in the apical pole
by all GPCR of pancreatic acini and the variable sensitivity of
different cellular regions to IP3-mediated Ca
2 release
prompted us to determine localization of GPCR in pancreatic
acini and to examine their autonomous behavior and what
mechanism they use to evoke quantal release. We report that
expression of GPCR is highly enriched in the apical pole, at or
just underneath the tight junctions. This provides an explana-
tion of how Ca2 waves are initiated at the apical pole. The
initiation site and propagation pattern of Ca2 waves are re-
ceptor-specific in the same cells. This appears to be the result of
autonomous coupling of receptors to G proteins and thus oper-
ation of GPCR signaling complexes. Finally and most notably,
by using agonist concentration jump protocols and inhibition of
the sarco/endoplasmic reticulum Ca2-ATPase (SERCA) pump
of partially stimulated cells, we provide evidence that the quan-
tal properties of Ca2 release are due to an all-or-none Ca2
release from a compartmentalized Ca2 pool.
EXPERIMENTAL PROCEDURES
Materials—Thapsigargin was from Alexis. The anti-muscarinic
monoclonal antibody (mAb) M35 was from Argene. The hybridoma cells
producing the 5H9 mAb against muscarinic type 3 receptor (M3R) and
the specificity of the Abs were described elsewhere (23). Two pAbs that
recognize different epitopes of the cholecystokinin (CCK) receptor were
prepared using peptide antigens, and their specificity was extensively
characterized and verified by blocking with peptides that were used to
raise the anti-CCKR antibodies (24). A recombinant M2R was a gener-
ous gift from Dr. Eliott Ross (University of Texas Southwestern Medical
Center, Dallas). Anti-IP3R2 pAb was a generous gift from Dr. Akihiko
Tanimura (University of Hokkaido, Ishikari-Tobetsu, Japan). The box
domain of RGS4 (4Box) was prepared as described (25). Anti-IP3R3
mAb and anti ZO1 pAbs were purchased from ABR and Zymed Labo-
ratories Inc., respectively. Anti-ZO1 mAb was obtained from the Hybri-
doma Bank at the University of Iowa.
Preparation of Pancreatic Acini and Single Acinar Cells—Acini were
prepared from the pancreas of 100–150-g rats by limited collagenase
digestion as described previously (6). After isolation, the acini were
resuspended in a standard solution A containing (in mM) 140 NaCl, 5
KCl, 1 MgCl2, 1 CaCl2, 10 Hepes (pH 7.4 with NaOH), 10 glucose, and
0.1% bovine serum albumin and kept on ice until use. Doublet or triplet
acinar cell clusters were obtained by incubation of a minced pancreas in
a 0.025% trypsin, 0.02% EDTA solution for 5 min at 37 °C. After
washing with solution A supplemented with 0.02% soybean trypsin
inhibitor, doublets and triplets were liberated by a 7-min incubation at
37 °C in the same solution that also contained 160 units/ml pure colla-
genase. The cells were washed with solution A and kept on ice until use.
[Ca2]i Imaging—Pancreatic acinar cells were loaded with Fura 2,
and [Ca2]i was imaged as detailed before (6). Fura 2 fluorescence was
measured at a single excitation wavelength of 380 nm, by averaging
eight consecutive images for each time point. Under these conditions
and using a frame size of 256 240 pixels, recording was at a resolution
of 90 ms/averaged image. During perfusion with the control solution
and just before the first stimulation, the image of resting cells was
acquired and was taken as the fluorescence signal at time 0 (F0). Pixel
values of all subsequent images were divided by this image, and the
traces and images are the calculated Ft/F0, where Ft is the fluorescence
at time t.
To calculate the distance between initiation sites from which Ca2
waves were triggered by different agonists or sequential application of
the same agonist in the same cell, the initiation sites of all waves were
marked on the first image, and the image was transferred to Adobe
Photoshop. A right triangle was drawn using the ray between the two
initiation sites as the hypotenuse. The x and y axes originated from the
left and top plane, respectively. The distance between the initiation
sites was then calculated by means of the Pythagorean theorem. The
distances from multiple experiments were averaged and are given as
means  S.E. Although this procedure allowed quantitative analysis of
the distance between initiation sites, such analysis has limitations
inherent to the imaging procedure. The most critical limitation is the
spatial resolution of cell imaging. The initiation sites and the waves are
three-dimensional, whereas imaging at a speed needed to capture Ca2
waves can be done only in two dimensions. Another limitation of the
measurement is the temporal resolution of our recording system. This
resulted in initiation sites that occupy 1–2 m2. Nevertheless, the
differences in Ca2 wave initiation sites and propagation pattern ob-
served when cells were stimulated with two different agonists were
sufficiently large to allow quantitative analysis of our measurements.
Electrophysiology—The whole cell configuration of the patch clamp
technique was used for measurement of Ca2-activated Cl current,
which correlates with changes in [Ca2]i near the plasma membrane
(26). The experiments were performed with single acinar cells perfused
with solution A. The standard pipette solution contained the following
(in mM): 140 KCl, 1 MgCl2, 0.5 EGTA, 5 ATP, 10 Hepes (pH 7.3 with
KOH) with or without 100 nM 4Box, as described in previous studies
(27). The 4Box was dialyzed against an ATP-free pipette solution and
concentrated to about 5 M with a centricone system. Seals of 6–10
gigohms were produced on the cell membrane, and the whole cell
configuration was obtained by gentle suction or voltage pulses of 0.5 V
for 0.3–1 ms. The patch clamp output (Axopatch-1B, Axon Instruments)
was filtered at 20 Hz. Recording was performed with patch clamp 6 and
a Digi-Data 1200 interface (Axon Instruments). All traces shown were
recorded at a holding potential of 40 mV.
Measurement of IP3—IP3 levels were measured by a radioligand
assay as described elsewhere (28). Acini in solution A were stimulated
with the indicated combination of agonists for 10 s at 37 °C. The
reactions were stopped by addition of 20 l of ice-cold 20% perchloric
acid to 200 l of samples, vigorous mixing, and incubation on ice for at
least 10 min to allow precipitation of proteins. The supernatants were
collected and transferred to clean tubes. Standards of IP3 were prepared
in the same manner. The perchloric acid was removed and IP3 extracted
by the addition of 0.15 ml of Freon and 0.15 ml of tri-n-octylamine. IP3
content in the aqueous phase was measured by displacement of [3H]IP3
using microsomes prepared from bovine brain cerebella (28).
Immunocytochemistry—The immunostaining procedure was de-
scribed previously (29). In brief, cells attached to glass coverslips were
fixed and permeabilized with cold methanol. After removal of methanol,
nonspecific sites were blocked by a 1-h incubation in blocking medium
prior to incubation with 50 l of blocking medium containing control
serum (controls) or the following antibodies: 1:500 dilution of the M35
mAb that recognizes all muscarinic receptors; the same mAbs that were
reabsorbed with recombinant M2R; 1:250 dilution of the 5H9 mAb
recognizing the M3R; 1:200 dilution of pAb specific for the M3R; 1:50
dilution of pAb1 and a 1:100 dilution of pAb2 that recognize the CCK
receptor; 1:200 dilution of mAb against IP3R3; 1:100 dilution of pAb
against IP3R2; 1:20 dilution of mAb against ZO1; and 1:100 dilution of
pAb recognizing ZO1. After incubation with the various primary anti-
bodies overnight at 4 °C, the cells were washed three times with the
incubation buffer. For the experiment with the 5H9 mAbs in Fig. 4A,
two different protocols were used. The first was a standard protocol
using permeabilized cells. Under these conditions, all pools of M3R were
detected. Because this antibody recognizes an extracellular epitope of
the M3R diagnostic of Sjo¨gren syndrome (23), it was used to label the
receptors in the plasma membrane by incubating a 0.5-ml suspension of
intact cells with 50 l of 5H9 mAb for 30 min at 37 °C. The cells were
then washed 3 times with phosphate-buffered saline to remove excess
antibodies before fixation with 0.5 ml of cold methanol. All steps post-
fixation were the same as with permeabilized cells. The primary Abs
were detected with goat anti-rabbit or anti-mouse IgG tagged with
fluorescein or rhodamine. Images were collected with a Bio-Rad MRC
1024 confocal microscope.
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RESULTS
Receptor-specific Ca2 Waves—Repetitive stimulation of
pancreatic acinar cells with the same high concentration of
agonist evokes Ca2 waves with the same initiation site and
propagation pattern (6). The quantal properties of agonist-
mediated Ca2 release (15) raised the question of whether
partial and maximal discharge of the pool generates the same
or different Ca2 waves. In particular, it was of interest to
determine whether the wave initiates from the same site at low
and high IP3 concentrations generated by weak and intense
agonist stimulation. The properties of Ca2 waves evoked by
repetitive, brief stimulation with increasing concentration of
agonist (5, 50, and 500 M carbachol) are depicted in Fig. 1.
Similar results were obtained in seven different cell prepara-
tions. All experiments were performed with clusters of doublet
or triplet cells to ensure polarized expression of signaling pro-
tein was maintained. The arrowheads in the first image of each
series show that the initiation site is constant and is independ-
ent of the IP3 concentration used to initiate the wave. The
calculated distance between initiation sites (see “Experimental
Procedures”) averaged 0.19  0.05 m (n  7). The diameter of
an acinar cell was about 20 m. In addition, the pattern of
wave propagation remained constant at all agonist concentra-
tions. Increased stimulation intensity only increased the rate of
Ca2 wave propagation.
Constant initiation site and propagation patterns of Ca2
waves were also observed with repetitive stimulation of an-
other GPCR, the CCK receptor (see below). However, in previ-
ous work (6) we reported that stimulations of multiple GPCRs
in the same rat pancreatic acinar cell evoked receptor-specific
FIG. 1. Ca2 wave initiation site and pattern are independent of [IP3]. Fura 2-loaded doublet or triplet cell clusters were stimulated with
5, 50, and 500 M carbachol. The cells were perfused with solution A for 3 min between the stimulations. The top left bright field image is  600
magnification and the middle image is  1000 magnification of the cell marked by an asterisk. The top right image shows the Fura 2 ratio under
resting conditions. The first image in each row shows the first detected [Ca2]i increase by the respective carbachol concentration. The arrowheads
mark the exact same spot in each image, demonstrating the same initiation site at all carbachol concentrations. The sequential images show the
identical Ca2 wave patterns at all carbachol concentrations. The bottom panel show the changes in Ft/F0 ratios during the [Ca
2]i rise phase for
the three carbachol concentrations. Traces 1–5 show the [Ca2]i changes in the areas marked 1–5 in the bright-field image. Please note the different
times at top left of each sequence of images and the different time scales for the traces at each agonist concentration, demonstrating the effect of
increased agonist concentration on the speed of the wave. AM, apical membrane; BM, basal membrane; SG, secretory granule; N, nucleus.
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Ca2 waves in terms of initiation sites and propagation pat-
terns. Cancela et al. (30) used mouse pancreatic acinar cells to
suggest that Ca2 waves are stochastic and are similar for all
GPCRs in a given cell. Therefore, we examined Ca2 waves
evoked by carbachol and CCK stimulation in the same cell of
small acinar clusters. Fig. 2 shows three examples of five ex-
periments with similar results. The cells were stimulated with
submaximal agonist concentrations to increase the temporal
resolution of the waves. The white (carbachol) and magenta
(CCK) arrowheads in the first image of each experiment show
that, without exception, the initiation site of Ca2 waves was
different between the two agonists. The calculated distance
between the carbachol and CCK initiation averaged 4.5  1.5
m (range 1.2–9.1 m, n  5). Although the waves initiated by
stimulation of the two receptors propagated along the cell pe-
riphery, differences in wave patterns were noticeable in most
experiments. Close examination of the results in Fig. 5A of
Cancela et al. (30) also show that in a single isolated mouse
pancreatic acinar cell activation of the muscarinic and CCK
receptors resulted in different initiation sites of Ca2 waves.
This is particularly evident when the third image of the ace-
tylcholine series is compared with the second image of the CCK
series. The Ca2 waves evoked by the two GPCRs had different
spatial propagation pattern.
Autonomous Behavior of Signaling Complexes—The con-
stancy of Ca2 waves evoked by repetitive stimulation of the
same GPCR, their independence of stimulus intensity, and the
different Ca2 wave evoked by activation of different GPCRs in
the same cell suggest autonomous functioning of GPCRs. We
used two experimental protocols to test this prediction. In the
first set of experiments we examined IP3 production by maxi-
mal agonist concentrations added individually or in combina-
tion. Although maximal stimulation of each of the GPCRs can
mobilize the entire Ca2 pool (see below), Fig. 3A shows that all
combinations of agonists produced a nearly additive increase in
IP3 concentration. Hence, each GPCR can activate different
pools of cellular PLC or distinct portions of a single pool that
is in excess to the total number of GPCRs.
In the second protocol we used the RGS domain of RGS4
(4Box) to demonstrate autonomous functioning of the GPCRs
FIG. 2. Receptor-specific initiation site and propagation pattern of Ca2 waves. Cells were sequentially stimulated with 5 M carbachol
and 0.25 nM CCK, as indicated in the traces in the upper panel. A shows the initiation site and pattern of the Ca2 wave evoked by activation of
the two receptors in the same cell. B and C show additional examples of the different Ca2 wave initiation sites evoked by carbachol (white
arrowhead) and CCK (magenta arrowhead) stimulation in the same cells. AM, apical membrane; BM, basal membrane.
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in the same cell. The 4Box lacks receptor recognition domain
and is a poor inhibitor of signaling in resting cells (31). The
4Box binds to activated -subunits of G proteins (25, 32) and is
nearly as effective as full-length RGS4 in stimulating GTPase
activity of Gq (31). Consequently, upon cell stimulation the
4Box is recruited to signaling complexes to inhibit their activity
and remains trapped in the complexes for as long as the cells
are stimulated (see Ref. 27 for further details on the mode of
action of the 4Box). We took advantage of the mode of interac-
tion of the 4Box with GPCR signaling complexes to examine
whether maximal activation of one GPCR type is sufficient to
recruit 4Box to all GPCRs complexes, or stimulation of each
GPCR complex is needed to inhibit signaling of the stimulated
complex. Fig. 3, B and C, shows that stimulation of cells with 1
mM carbachol resulted in complete mobilization of the Ca2
pool, as evident from the failure of 10 nM CCK8 and 100 nM
bombesin (BS) to increase [Ca2]i in cells continuously stimu-
lated with carbachol. When the cells were infused with 100 nM
4Box, stimulation with 1 mM carbachol resulted in a maximal
initial signal that terminated rapidly and returned to base line
at continuous stimulation with carbachol, due to receptor-de-
pendent recruitment and trapping of 4Box (27). Fig. 3, D and E,
shows that at continuous stimulation with carbachol the cells
responded with a maximal signal to CCK8 (n  15) and BS
stimulation (n  4). The response to CCK8 and BS had the
same kinetics as that to carbachol, with a rapid onset and
inhibition, and it remained inhibited for the duration of cell
stimulation. This behavior is best explained if the various
receptors are coupled to separate pools of cellular Gq and
PLC.
Polarized Expression of Ca2 Signaling Proteins and Recep-
tors—Polarized and restricted expression of Ca2 channels and
Ca2 pumps in the luminal pole of epithelial cells appears to be
important for initiation and propagation of polarized Ca2
waves (7, 33). Co-immunoprecipitation of various Ca2 signal-
ing proteins indicates organization of the proteins into com-
plexes in cellular microdomains (29). GPCRs are believed to be
expressed mostly in the basal membrane. However, a recent
report (34) suggested the possible expression of selective
GPCRs next the luminal pole in rat goblet cells. With the
development of selective antibodies that recognize several
GPCRs, it was of interest to re-examine localization of GPCRs
in pancreatic acini. Fig. 4 demonstrates the co-localization of
the type 3 muscarinic (M3Rs) and CCK receptors (CCKRs) with
Ca2-signaling proteins. Both receptors are expressed at high
levels at the apical pole of pancreatic acini. Several antibodies
used to localize the M3Rs revealed two cellular pools of these
receptors, a plasma membrane and a Golgi-like pools. Double
staining with pAb recognizing M3Rs and ZO1, a specific tight-
junction protein (Fig. 4A, top panels), or IP3R2 (not shown)
showed that M3Rs localized in a non-uniform fashion with high
levels at the lateral border, in close proximity or at the tight
junctions, and low levels at the basal region (n  10). However,
the M35 and the 5H9 mAbs showed different patterns of local-
ization. In permeabilized cells, the two mAbs showed strong
labeling of an intracellular compartment and lower staining of
the plasma membrane (n  9 for M35, n  6 for 5H9). This is
particularly evident with the M35 mAb (Fig. 4, lower middle
panel). The staining with this mAb was eliminated by adsorb-
ing the mAb with recombinant M2Rs (Fig. 4, lower left panel),
demonstrating specificity of the Abs. Because the 5H9 mAbs
recognize an extracellular epitope evident of Sjo¨gren syndrome
(23), the plasma membrane staining was isolated by incubating
intact cells with the Ab prior to cell fixation and permeabiliza-
tion. Fig. 4A, lower right panel, shows that the M3Rs receptors
are highly localized to the lateral membrane next to tight
junctions (n  4).
Selective localization was also observed with the CCKRs
using two different pAbs recognizing different domains of the
receptor, a pAb raised against amino acids 30–42 and a pAb
raised against amino acids 411–429 of the type A CCKR (24).
The two Abs specifically recognized recombinant and native
CCKRs. Localization of the CCKRs at the apical pole of the
lateral membrane (Fig. 4B) was similar to that of the M3Rs at
the plasma membrane. The CCKRs at the plasma membrane
were concentrated very near the IP3R3 at the apical pole (n 
10). The anti-CCKRs Abs did not recognize a Golgi pool of this
receptor.
Quantal Behavior and an All-or-None Ca2 Release—The
independence of the Ca2 waves initiation site and propagation
pattern of IP3 concentration (Fig. 1) offered us the opportunity
to examine whether local Ca2 release is due to an all-or-none
release from a compartmentalized pool (Fig. 5, model A) or a
partial release from a continuous pool (Fig. 5, model B). The
experiments used to distinguish between the two models and
their predicted outcome according to each model are depicted in
Fig. 5. Resting cells are in state a. Shortly after cell stimulation
with submaximal agonist concentration (state b), all the Ca2 is
released from a sub-compartment of the pool (model A) or part
of the Ca2 is released from the entire pool (model B). At
continuous stimulation (state c), high [Ca2]i at the mouth of
the IP3Rs reduces channel activity to allow partial reloading of
the just discharged sub-pool with Ca2 by the activated SERCA
pumps (35) (model A). In this scenario, Ca2 permeability of
the sub-pool remains elevated, whereas Ca2 permeability of
the remaining pool is similar to that in resting cells. By con-
FIG. 3. Autonomous behavior of GPCR complexes. A shows
stimulation of IP3 production by 1 mM carbachol (Car), 10 nM CCK8b,
and 100 nM BS alone (open column) and combinations of two (gray
columns) or the three agonists (filled column). B–E show the Ca2-
activated Cl current recorded from control cells or cells dialyzed with
100 nM 4Box for 7 min before the first stimulation. The bars indicate
where the cells were stimulated with the indicated agonist concentra-
tion. Note that CCK8 and BS had no effect on [Ca2]i in carbachol-
stimulated cells under control conditions but evoked a maximal re-
sponse in cells dialyzed with 4Box.
[Ca2]i Waves and an All-or-None Ca
2 Release44150
 at Y
O
N
SEI U
N
IV
ERSITY
 on A
ugust 5, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
trast, model B assumes that at continuous stimulation, the
activity of all the IP3Rs channels is adapted to the lower Ca
2
content in the entire pool to terminate Ca2 release so that
Ca2 permeability of the pool is similar to that of resting cells.
The first protocol we used is an agonist concentration jump
after state c, long after return of [Ca2]i to near resting level.
Model A predicts that the agonist (or IP3) concentration jump
will generate a Ca2 wave with the same initiation site and
pattern. Model B predicts generation of Ca2 waves from ran-
dom initiation sites and propagation pattern, because of the
adaptation of the IP3Rs that generated the first wave. Fig. 6
shows the results of such experiments with carbachol and CCK.
It is clear that the Ca2 waves initiated by low agonist and the
concentration jump have the same initiation site and propaga-
FIG. 4. Polarized expression of
GPCRs, ZO1, and IP3Rs. Isolated pan-
creatic acini were fixed and stained with
the following Abs: A, upper panels, double
staining with anti-ZO1 and anti-M3Rs;
middle panels, double staining with anti-
ZO1 and the anti-M3R mAb clone 5H9
after cell permeabilization; lower left
panel, staining with the anti-muscarinic
receptors mAb M35 pre-adsorbed with re-
combinant M2 receptors; middle panels,
double staining with anti-M3Rs clone
M35 and anti-ZO1; lower right panel,
staining with anti-M3Rs mAb clone 5H9
in intact cells before permeabilization
(see “Experimental Procedures”). B, main
panels, double staining with anti-CCKRs
raised against amino acids 411–429 of the
CCKR and anti-ZO1 or anti-IP3R2, as in-
dicated; right panel, staining with an Ab
that was raised against amino acids
30–42 of the CCKR.
FIG. 5. Models of quantal Ca2 re-
lease. Model A illustrates quantal Ca2
release by an all-or-none mechanism and
model B Ca2 release by IP3Rs adaptation
mechanism. The text depicts the pre-
dicted outcomes of the agonist concentra-
tion jump and SERCA pump inhibition
protocols by each model.
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tion pattern. In five experiments with carbachol and four ex-
periments with CCK, the average distances between the two
initiation sites were 0.16  0.03 and 0.10  0.03 m, respec-
tively. Localized generation of IP3 due to the polarized expres-
sion of the muscarinic receptors is likely to contribute to the
constancy of the wave. Hence, in addition to testing the first
prediction in Fig. 5, the constancy of the wave observed with
the protocol of Fig. 6 lend further support for the autonomous
behavior of signaling complexes
In the second protocol, the second Ca2 wave was initiated
by applying the concentration jump at the end of Ca2 release
evoked by the low agonist and before any reduction in [Ca2]i
due to IP3Rs channel adaptation. Model A predicts a second
Ca2 wave with different initiation site, due to discharge of all
the Ca2 from the pool mobilized by low agonist. Model B
predicts a second Ca2 wave from the same initiation site
because Ca2 is released prior to adaptation of the IP3Rs acti-
vated by the first stimulus. The trace in Fig. 7 shows that this
particular cell was exposed to the supermaximal concentration
of 5 mM carbachol at 1.63 s after simulation with 5 M carba-
chol. The concentration of 5 mM was used for the second stim-
ulus, which was applied by rapid injection from a needle adja-
cent to the cell, to minimize the delay between agonist
application and cell stimulation. The images in Fig. 7 show the
results of four of five independent experiments with similar
results. In contrast with the prediction of model B, but as
predicted by model A, in all experiments the second Ca2 wave
evoked by the agonist concentration jump was initiated at a
FIG. 6. Successive stimulation by a delayed agonist concentration jump. A, the cell was stimulated with 5 M carbachol, and after return
of Ca2 to basal levels carbachol concentration was rapidly increased to 0.5 mM. B, the cell was stimulated with 0.25 nM CCK, and after return of
Ca2 to resting levels CCK concentration was increased to 10 nM. The white arrowheads show the Ca2 wave initiation site for each stimulation
period. Note the same initiation site by the low and high agonist concentrations in all experiments.
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different site than the first Ca2 wave. The calculated distance
between the initiation sites averaged 7.3  1.3 m (range
3.3–10.9 m, n  5), which is statistically different (p  0.01)
from the 0.19  0.05 m measured after delayed application of
carbachol.
A shift in the initiation site of Ca2 waves when the second
wave was initiated at the end of the first Ca2 release (Fig. 7)
can be either because the initiation site still contained Ca2 but
the IP3Rs at this site became refractory to a jump in IP3
concentration, or because all the Ca2 was released from this
site by the first stimulus, and Ca2 re-uptake is needed to
initiate a second Ca2 wave from the same site. The results in
Fig. 8 provide direct evidence that Ca2 release is an all-or-
none process and that Ca2 uptake must occur to initiate
multiple Ca2 waves from the same site. In these experiments
we blocked the SERCA pumps with 10 M thapsigargin (Tg) at
different times after initiation of a Ca2wave. Model A predicts
that inhibition SERCA pumps of cells continuously stimulated
with low agonist at any time will trigger a Ca2 wave with the
same initiation site and pattern. Model B predicts that inhibi-
tion of SERCA pumps will not trigger a wave but rather will
cause slow Ca2 release because of adaptation of all IP3Rs. Fig.
8A shows that in the absence of agonist stimulation, Tg caused
a slow, peripheral to central Ca2 release with no apparent
Ca2 wave or preferential release from any cellular region. As
shown by the trace in Fig. 8A, [Ca2]i continued to increase for
at least 30 s after exposure to Tg. Hence, in the absence of
agonist stimulation Tg never initiated a Ca2 wave.
Very different results were obtained when the cells were
stimulated with submaximal agonist concentration and al-
lowed to reduce [Ca2]i back to near basal level. As shown in
Fig. 8B, under these conditions Tg evoked rapid, luminal to
basal Ca2 waves. Remarkably, in all experiments the Tg-
evoked Ca2 waves had the same initiation site and propaga-
tion pattern as the first Ca2 wave evoked by the agonists. The
distance between the initiation sites of the first waves evoked
by carbachol and the second waves evoked by Tg in the same
cells averaged 0.25  0.1 m (n  5), which is not different
from the 0.16  0.03 m measured with delayed concentration
jump. The traces in C show that the magnitude of Ca2 release
by Tg was dependent on the incubation time with agonist.
Thus, simultaneous stimulation of the cells with 5 M carba-
chol and 10 M Tg resulted in a rapid Ca2 release but slow
FIG. 7. Successive stimulation by a rapid agonist concentration jump. The trace shows the experimental protocol and the Ft/F0 ratio of
a typical experiment. The cells were stimulated with 5 mM carbachol at the peak of the [Ca2]i increase evoked by 5 M carbachol. The images in
A–D show the initiation site of the Ca2 waves evoked by rapid, consecutive application of 5 M (white arrowhead) and 5 mM carbachol (magenta
arrowhead) to the same cells. Note the different initiation sites by the low and high agonist concentrations in all experiments.
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return of [Ca2]i to basal levels, much slower than the rate
observed with agonist alone (compare red to all other traces in
C). Application of Tg at different times after cell stimulation
caused a rapid increase in [Ca2]i, to approximately the same
level as that caused by the agonist and a slow reduction toward
basal levels. Hence, Tg rapidly discharged only the Ca2 that
was incorporated into the initiation site during continuous
stimulation and never to a level significantly higher than the
initial level caused by the agonists. This behavior indicates
that Ca2 release from the initiation site must be an all-or-
none process and that the initiation site reloads with Ca2
during continuous stimulation with submaximal agonist con-
centration (model A). Furthermore, this behavior is incompat-
ible with model B.
FIG. 8. Ca2 waves are evoked by inhibition of SERCA pumps in cells continuously stimulated with low agonist concentration. A,
maximal inhibition of SERCA pumps by 10 M thapsigargin (Tg) in resting cells causes a slow peripheral to central Ca2 release. B, maximal
inhibition of SERCA pumps by Tg in cells continuously treated with 5 M carbachol after return of [Ca2]i to basal level launch a Ca
2 wave with
the same initiation site (white arrowheads) and propagation pattern as the initial wave evoked by carbachol. C, cells were stimulated with 5 M
carbachol (a) or 0.25 nM CCK (b). At different times during the reduction of [Ca2]i to basal levels, SERCA pumps were inhibited with 10 M Tg.
In all cases Tg evoked a rapid increase in [Ca2]i (in the form of a luminal-to-basal Ca
2 wave) with a subsequent slow reduction in [Ca2]i.
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DISCUSSION
In the present work we addressed two important topics in
Ca2 signaling: how luminal to basal Ca2 waves can be gen-
erated in a receptor-specific manner and whether quantal Ca2
release reflects partial release from a continuous pool or an
all-or-none release from a compartmentalized pool. Polarized
exocrine cells are a good model system to address these ques-
tions because of the polarized nature of their Ca2 signals (3),
the polarized expression of high levels of Ca2 transport pro-
teins in the apical pole (7, 9, 29, 33, 36), and the generation of
receptor-specific Ca2 signals in these cells (6, 37). Our results
indicate that signaling specificity in pancreatic acinar cells is
aided by polarized expression and autonomous functioning of
GPCRs and that quantal Ca2 release is due to an all-or-none
Ca2 release from a compartmentalized Ca2 pool.
Signaling specificity is a central topic in cell signaling (38).
Several mechanisms have been shown to contribute to gener-
ation of specific GPCR-dependent Ca2 signals, which include
selective phosphorylation of IP3Rs (39), differential couplings
of Ca2 release to Ca2 entry (40), and different involvement of
cADP-ribose and NADP-mediated Ca2 release in the response
(30). However, ultimately signaling specificity must reside in
the communication between the receptor and downstream ef-
fectors. Indeed, RGS proteins function in a receptor-specific
manner to confer receptor-specific signaling (41). Interaction of
receptors with effectors requires their co-localization in cellular
microdomains at sites of Ca2 release. In polarized exocrine
cells Ca2 waves are always initiated at the apical pole.
Whereas expression of all known IP3R isoforms (7, 9), specific
isoforms of SERCA pumps (33), and plasma membrane Ca2
ATPase pumps (36) has been demonstrated, it remains a puzzle
as to how IP3 can be generated at this cellular microdomain
because GPCRs are believed to reside largely at the basal pole.
The localization of the M3Rs and CCKRs found at the present
work clarifies this issue. The use of three anti-M3Rs and two
anti-CCKRs, which recognize different epitopes, showed that
both GPCR types are expressed at high level at close proximity
or at the tight junctions. This localization removes the need to
assume long range diffusion of IP3 from the basal to the apical
pole to initiate Ca2 waves. Moreover, such localization of
GPCRs is likely to contribute to the constancy of the Ca2
waves generated by repetitive stimulation of the same GPCR
complex.
In the present work we confirmed and extended the finding
of receptor-specific Ca2 waves by various GPCRs expressed in
the same cell. By using the unique property of recruitment and
trapping of the 4Box within signaling complexes (27), we dem-
onstrated autonomous functioning of GPCRs. Furthermore,
production of IP3 by multiple GPCRs was nearly additive. The
combined findings indicate that different GPCRs communicate
with separate portions of the cellular pool of Gq and PLC to
generate IP3 at separate cellular microdomains. The finding
that the initiation site of Ca2 waves was independent of IP3
concentration, remaining constant when initiated by low (weak
stimulation) or high IP3 concentration (intense agonist stimu-
lation), indicates that each GPCR communicates with a sepa-
rate portion of the Ca2 pool at the apical pole to generate Ca2
waves with distinct initiation sites. Communication with a
distinct portion of the Ca2 pool may also reflect localized
generation of IP3 at the locus from which Ca
2 waves are
initiated. Measurement of IP3 in single pancreatic acinar cells
is needed to test this point. At present, this is not feasible.
Since the discovery of the quantal behavior of Ca2 release
(15), two models were proposed as possible mechanisms of this
phenomenon (see Fig. 5). The first model proposes that the
intracellular Ca2 pool is compartmentalized with respect to
Ca2 release, and the IP3R Ca
2 release channels in the dif-
ferent compartments have variable affinity to IP3 and Ca
2
release from individual compartments in an all-or-none process
(15, 20). The second model proposed that the intracellular Ca2
pool is continuous, and the affinity of all IP3Rs to IP3 is the
same but is sensitive to Ca2 content in the stores, and Ca2
release is incremental due to rapid inactivating adaptation of
the IP3Rs (21). The evidence in favor of the adaptation model is
the finding that stored Ca2 regulates the affinity of the IP3Rs
for IP3 in virtually all cell types examined (42), and a recent
report (22) indicates that two rapid successive increases in IP3
can liberate Ca2 from the same site. The first evidence (42) is
not mutually exclusive with the all-or-none model, and in the
second case (22) rapid Ca2 re-uptake into the stores was not
prevented by inhibition of the SERCA pumps which, as shown
in the present work, can explain the second Ca2 release event.
Previous evidence in support of the all-or-none model was
developed by measurement of Ca2 permeability of the stores
at increasing stimulus intensity (15). Increased agonist concen-
tration mobilized a larger fraction of the Ca2 pool. At persis-
tent stimulation with submaximal agonist concentrations,
Ca2 permeability of the mobilized fraction of the pool re-
mained very high, whereas Ca2 permeability of the immobi-
lized fraction remained very low, identical to that measured in
resting cells (15). Another important finding in support of the
all-or-none model is the variable sensitivity of IP3 to Ca
2
release from different regions of pancreatic acinar cells (3, 11).
The adaptation model predicts uniform IP3 sensitivity through-
out the cell.
In the present work we provide what we believe is strong
evidence in support of the all-or-none model by first showing
that the initiation site of Ca2 waves is independent of IP3
concentration. The implication of this finding is that there
must exist a sub-pool that is more sensitive to IP3 than the
remaining cellular Ca2 pool, and this pool is always dis-
charged first upon cell stimulation. This provides additional
evidence that the cellular Ca2 pool is not uniform with respect
to sensitivity to IP3. Next, we used an agonist concentration
jump to apply two consecutive rapid or delayed applications of
IP3. This protocol is equivalent to the two consecutive IP3
application protocols used to conclude multiple Ca2 release
events from the same site (22). Two consecutive applications of
IP3 in pancreatic acini released Ca
2 from two separate sites
when the second application was applied immediately at the
end of Ca2 release by the first application (Fig. 7). The differ-
ence between our results and those obtained in Xenopus oo-
cytes (22) can be due to species differences or partial reloading
of the just released pool with Ca2.
The adaptation model requires that at continued exposure to
the same IP3 concentration, the IP3R channels adapt, becoming
refractory to IP3, and Ca
2 permeability of the pool is reduced
back to resting level to terminate Ca2 release. We used Tg to
provide compelling evidence that this is not the case, at least in
pancreatic acini. In fact, the Ca2 pool liberated by submaxi-
mal receptor stimulation reloads with Ca2 with continuous
exposure to a constant agonist concentration. Furthermore,
and most important, the Ca2 permeability of the released and
reloaded pool remains high, resulting in a Tg-evoked Ca2
wave. The Tg-evoked Ca2 wave had the same initiation site
and propagation pattern as the Ca2 wave evoked by the ago-
nist (Fig. 8). Hence, the maintained high Ca2 permeability of
the liberated sub-pool, reloading of the sub-pool at continued
stimulation, and the shift in the initiation site of Ca2 wave
observed at rapid agonist concentration jump are all compati-
ble only with an all-or-non model of Ca2 release. Therefore, we
conclude that the principal mechanism behind the quantal
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behavior of Ca2 release is an all-or-none Ca2 release from
highly compartmentalized intracellular Ca2 pool.
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